Diagnostic challenges in subcorneal pustular dermatosis
- Authors: Olisova O.Y.1, Teplyuk N.P.1, Grabovskaya O.V.1, Grekova E.V.1, Shepeleva A.V.1, Zokirova A.S.1, Bagdasaryan G.A.1, Miagkova A.А.1
-
Affiliations:
- The First Sechenov Moscow State Medical University
- Issue: Vol 28, No 6 (2025)
- Pages: 730-740
- Section: DERMATOLOGY
- URL: https://ogarev-online.ru/1560-9588/article/view/367130
- DOI: https://doi.org/10.17816/dv684371
- EDN: https://elibrary.ru/BJNVZP
- ID: 367130
Cite item
Abstract
Subcorneal pustular dermatosis, also known as Sneddon–Wilkinson disease, is a rare recurrent condition, and its nosology remains a subject of debate. It is often placed within the spectrum of bullous dermatoses and interpreted as a subtype of pemphigus; however, some contemporary studies consider it a neutrophilic dermatosis, and even a potential variant of pustular psoriasis.
Clinically, Sneddon–Wilkinson disease presents with eruptions on normal or erythematous skin in the form of flaccid, superficial, small (2–4 mm) sterile pustules, which are often grouped, forming annular or garland-like patterns. The process is typically symmetrical.
The etiopathogenesis remains incompletely understood, though current evidence indicates that the key pathogenic mechanism is the accumulation of neutrophils beneath the stratum corneum, possibly due to an abnormal neutrophilic response to aberrant chemotactic factors located within the upper epidermal layers.
Diagnosis of Sneddon–Wilkinson disease is challenging, because its clinical presentation closely resembles several other conditions. Another difficulty is in the need to distinguish subcorneal pustular dermatosis from pustular psoriasis. Diagnosis is based on clinical presentation and histopathological examination, where subcorneal neutrophilic accumulation is key.
The issue of treatment for this type of dermatosis remains relevant, with dapsone being the first-line option. In cases of poor response or contraindications, alternative modalities may be used, including systemic glucocorticoids, retinoids, PUVA therapy, and tumor necrosis factor-α (TNF-α) inhibitors.
This article presents a rare clinical case of Sneddon–Wilkinson disease in a 20-year-old pregnant patient in her second trimester, with a year-long disease history, diagnostic difficulties, and challenges in therapeutic management.
About the authors
Olga Y. Olisova
The First Sechenov Moscow State Medical University
Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN-code: 2500-7989
MD, Dr. Sci. (Medicine), Professor, Corresponding Member of the Russian Academy of Sciences
Russian Federation, MoscowNatalya P. Teplyuk
The First Sechenov Moscow State Medical University
Email: teplyukn@gmail.com
ORCID iD: 0000-0002-5800-4800
SPIN-code: 8013-3256
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowOlga V. Grabovskaya
The First Sechenov Moscow State Medical University
Email: olgadoctor2013@yandex.ru
ORCID iD: 0000-0002-5259-7481
SPIN-code: 1843-1090
MD, Cand. Sci. (Medicine), Professor
Russian Federation, MoscowEkaterina V. Grekova
The First Sechenov Moscow State Medical University
Author for correspondence.
Email: grekova_kate@mail.ru
ORCID iD: 0000-0002-7968-9829
SPIN-code: 8028-5545
MD, Cand. Sci. (Medicine), Assistant Professor
Russian Federation, MoscowAnastasia V. Shepeleva
The First Sechenov Moscow State Medical University
Email: dr.shepelevaavl@gmail.com
ORCID iD: 0009-0001-5251-5394
Russian Federation, Moscow
Anisa S. Zokirova
The First Sechenov Moscow State Medical University
Email: zokirovaanisa@mail.ru
ORCID iD: 0009-0008-9694-9363
Russian Federation, Moscow
Goarik A. Bagdasaryan
The First Sechenov Moscow State Medical University
Email: goga05022001@yandex.ru
ORCID iD: 0009-0004-0638-6992
Russian Federation, Moscow
Anastasiia А. Miagkova
The First Sechenov Moscow State Medical University
Email: myan_03@mail.ru
ORCID iD: 0009-0007-7602-0162
Russian Federation, Moscow
References
- Romagnuolo M, Muratori S, Cattaneo A, et al. Successful treatment of refractory Sneddon-Wilkinson disease (subcorneal pustular dermatosis) with infliximab. Dermatol Ther. 2022;35(7):e15552. doi: 10.1111/dth.15552 EDN: ANEMIW
- Drozhdina MB, KoshkiN SV. Sneddon-Wilkinson disease: review of the modern literature. Vestnik dermatologii i venerologii. 2019;95(1):15–20. doi: 10.25208/0042-4609-2019-95-1-15-20 EDN: FXIFZK
- Cheng S, Edmonds E, Ben-Gashir M, et al. Subcorneal pustular dermatosis: 50 years on. Clin Exp Dermatol. 2008;33(3):229–233. doi: 10.1111/j.1365-2230.2008.02706.x
- Sneddon IB, Wilkinson DS. Subcorneal pustular dermatosis. Br J Dermatol. 1979;100(1):61–68. doi: 10.1111/j.1365-2133.1979.tb03570.x
- Dyudyun AD, Romanenko KV, Ivneva SV, et al. A clinical case of subcorneal pustular dermatosis (Sneddon-Wilkinson disease) on the background of atopic dermatitis. Dermatovenerology. Cosmetology. Sexopathology. 2015;(3-4):216–222. EDN: WMFPSH
- Watts PJ, Khachemoune A. Subcorneal pustular dermatosis: a review of 30 years of progress. Am J Clin Dermatol. 2016;17(6):653–671. doi: 10.1007/s40257-016-0202-8 EDN: TRQTAU
- Naik HB, Cowen EW. Autoinflammatory pustular neutrophilic diseases. Dermatol Clin. 2013;31(3):405–425. doi: 10.1016/j.det.2013.04.001
- Alhafi MA, Janahi MI, Almossalli ZN. Subcorneal pustular dermatosis in paediatrics: a case report and review of the literature. Cureus. 2021;13(12):e20221. doi: 10.7759/cureus.20221 EDN: AXYQOF
- Karacheva YV, Smykova AN. Subcorneal pustular dermatosis of Sneddon-Wilkinson: сlinical case. Russian Journal of Skin and Venereal Diseases. 2018;21(1):28–30. doi: 10.18821/1560-9588-2018-21-1-28-30 EDN: UTYSTY
- Raznatovskii KI, Piriatinskaia VA, Kariakina LA, et al. Pustular dermatosis (Sneddon-Wilkinson disease): case study. Russian Journal of Clinical Dermatology and Venereology. 2017;16(3):36–40. doi: 10.17116/klinderma201716336-39 EDN: ZCIMNJ
- Tajiri K, Nakajima T, Kawai K, et al. Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma. Intern Med. 2015;54(6):597–600. doi: 10.2169/internalmedicine.54.3675
- Iurillo A, YumeeN S, Imbriano D, et al. Subcorneal pustular dermatosis following SARS-CoV-2 infection. R I Med J (2013). 2023;106(10):51–53.
- Johnston A, Xing X, Wolterink L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109–120. doi: 10.1016/j.jaci.2016.08.056
- Abreu Velez AM, Smith JG, Howard MS. Subcorneal pustular dermatosis an immnohisto-pathological perspective. Int J Clin Exp Pathol. 2011;4(5):526–529. EDN: YCUDMX
- Razera F, Olm GS, Bonamigo RR. Neutrophilic dermatoses: part II. An Bras Dermatol. 2011;86(2):195–211. doi: 10.1590/s0365-05962011000200001
- Delaleu J, Lepelletier C, Calugareanu A, et al. Neutrophilic dermatoses. Rev Med Interne. 2022;43(12):727–738. doi: 10.1016/j.revmed.2022.06.007 EDN: XWKBPD
- Hensley CD, Caughman SW. Neutrophilic dermatoses associated with hematologic disorders. Clin Dermatol. 2000;18(3):355–367. doi: 10.1016/s0738-081x(99)00127-3
- Delaporte E, Colombel JF, Nguyen-Mailfer C, et al. Subcorneal pustular dermatosis in a patient with Crohn’s disease. Acta Derm Venereol. 1992;72(4):301–302. doi: 10.2340/0001555572301302
- Butt A, Burge SM. Sneddon-Wilkinson disease in association with rheumatoid arthritis. Br J Dermatol. 1995;132(2):313–315. doi: 10.1111/j.1365-2133.1995.tb05037.x
- Ishii N. Significance of anti-desmocollin autoantibodies in pemphigus. J Dermatol. 2023;50(2):132–139. doi: 10.1111/1346-8138.16660 EDN: ITVIWH
- Brodehl A, Stanasiuk C, Anselmetti D, et al. Incorporation of desmocollin-2 into the plasma membrane requires N-glycosylation at multiple sites. FEBS Open Bio. 2019;9(5):996–1007. doi: 10.1002/2211-5463.12631
- Abdelhafez MM, Ahmed KA, Mohd Daud MN, et al. Impetigo herpetiformis: a rare pregnancy-specific dermatosis. Obset Med. 2023;16(1):5–8. doi: 10.1177/175349X221074610 EDN: BLIDOC
- Borzova IYu, Vertieva EYu, Grabovskaya OV, et al. An illustrated guide to dermatology: to prepare doctors for accreditation. Olisova OYu, Teplyuk NP, editors. Moscow: GEOTAR-Media; 2023. 373 p. (In Russ.)
- Sheu JS, Divito SJ, Enamandram M, et al. Dapsone therapy for pustular psoriasis: case series and review of the literature. Dermatology. 2016;232(1):97–101. doi: 10.1159/000431171
- Kretschmer L, Maul JT, Hofer T, et al. Interruption of Sneddon-Wilkinson subcorneal pustulation with infliximab. Case Rep Dermatol. 2017;9(1):140–144. doi: 10.1159/000468917
- Guerin C, Beylot-Barry M, Frouin E, et al. Treatment of subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with anti-tumor necrosis factor alpha. Cureus. 2021;13(8):e17147. doi: 10.7759/cureus.17147 EDN: BBOSML
- Keller M, Spanou Z, Schaerli P, et al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol. 2005;175(11):7678–7686. doi: 10.4049/jimmunol.175.11.7678
- Nakamizo S, Kobayashi S, Usui T, et al. Clopidogrel-induced acute generalized exanthematous pustulosis with elevated Th17 cytokine levels as determined by a drug lymphocyte stimulation test. Br J Dermatol. 2010;162(6):1402–1403. doi: 10.1111/j.1365-2133.2010.09705.x
- Ono S, Otsuka A, Miyachi Y, et al. Subcorneal pustular dermatosis exhibiting a high serum TARC/CCL17 level. Case Rep Dermatol. 2013;5(1):38–42. doi: 10.1159/000348241
- Kaminski VL, Ellwanger JH, Matte MC, et al. IL-17 bloods levels increase in healthy pregnancy but not in spontaneous abortion. Mol Biol Rep. 2018;45(5):1565–1568. doi: 10.1007/s11033-018-4268-7 EDN: FBLTSA
- Wanberg LJ, Schultz B, Goyal A. Treatment of subcorneal pustular dermatosis without dapsone: a case report and review of the literature. Case Rep Dermatol Med. 2024;2024:8140483. doi: 10.1155/2024/8140483 EDN: KEQAFG
- Korbi M, Amri F, Njima M, et al. Successful treatment of Sneddon-Wilkinson disease with doxycycline. Clin Exp Dermatol. 2021;46(8):1568–1569. doi: 10.1111/ced.14756 EDN: KZMFUU
- Ceccarelli G, Molinelli E, Campanati A, et al. Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: case report. Case Rep Dermatol. 2019;11(2):209–214. doi: 10.1159/000487003
- Karadoğan SK, Aydoğan K, Başkan EB, et al. A case of subcorneal pustular dermatosis treated successfully with a combination of cyclosporin and prednisolone. J Eur Acad Dermatol Venereol. 2007;21(4):536–537. doi: 10.1111/j.1468-3083.2006.01929.x
- Magdaleno-Tapial J, Valenzuela-Oñate C, Alonso-Carpio M, et al. Improvement of recalcitrant Sneddon-Wilkinson disease with apremilast. Australas J Dermatol. 2020;61(2):185–186. doi: 10.1111/ajd.13253 EDN: DGWWNF
- Hoshina D, Tsujiwaki M, Furuya K. Successful treatment of subcorneal pustular dermatosis with maxacalcitol. Clin Exp Dermatol. 2016;41(1):102–103. doi: 10.1111/ced.12680
- Yamaguchi Y, Oyama N, Koizumi H, et al. Successful treatment of recalcitrant subcorneal pustular dermatosis with oral nicotinamide. J Dermatol. 2019;46(11):e438–e440. doi: 10.1111/1346-8138.14980
- Falcone LM, Pilcher MF, Kovach RF, et al. Pentoxyfilline as a treatment for subcorneal pustular dermatosis. Dermatol Ther. 2019;32(2):e12818. doi: 10.1111/dth.12818
Supplementary files
